← Back to Search

Behavioural Intervention

AI-Augmented Motivational Interviewing for Chronic Disease (AIM-PC Trial)

N/A
Waitlist Available
Led By Paul J Hershberger, PhD
Research Sponsored by Wright State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 4-5, months 16-17, months 25-26, months 32-33
Awards & highlights
No Placebo-Only Group

Summary

This trial will look at how training primary care providers in motivational interviewing (MI) with the help of artificial intelligence (AI) can improve patient outcomes and clinician well-being. There will be a control

Who is the study for?
This trial is for primary care providers (PCPs) interested in improving patient engagement and managing chronic diseases more effectively. It aims to train PCPs in motivational interviewing (MI) techniques augmented by artificial intelligence (AI). Providers with an interest in reducing implicit bias and burnout are ideal candidates.
What is being tested?
The study tests the effectiveness of AI-augmented MI training on patient outcomes, clinician wellbeing, and reduction of biases. There's a control group receiving no special training, while two other groups receive varying levels of AI-enhanced MI training.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience changes in workload or stress levels due to new training procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 4-5, months 16-17, months 25-26, months 32-33
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 4-5, months 16-17, months 25-26, months 32-33 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
MI Communication Metrics
MI Spirit
Secondary study objectives
Aggregated Patient Data for Each Participating PCP
Bias Manifestation
Brief Resilience Scale (BRS)
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Control GroupActive Control1 Intervention
The control group (CG) will provide survey data and complete role plays with standardized patients for motivational interviewing (MI) assessment at designated project intervals. Premier Physician Network data for these primary care providers (PCPs) will also be obtained at these intervals.
Group II: BASIC AI-Augmented Motivational Interviewing TrainingActive Control1 Intervention
The Basic intervention group will provide survey data and complete role plays with standardized patients for motivational interviewing (MI) assessment at designated project intervals. Premier Physician Network data for these primary care providers (PCPs) will also be obtained at these intervals. Basic PCPs will participate in a didactics session on MI, and subsequently complete two AI (artificial intelligence)-augmented MI training sessions that involve role-play practice of MI.
Group III: PLUS AI-Augmented Motivational Interviewing TrainingActive Control1 Intervention
The Plus intervention group will provide survey data and complete role plays with standardized patients for motivational interviewing (MI) assessment at designated project intervals. Premier Physician Network data for these primary care providers (PCPs) will also be obtained at these intervals. Plus intervention group PCPs will participate in a didactics session on MI, and subsequently complete four AI (artificial intelligence)-augmented MI training sessions that involve role-play practice of MI.

Find a Location

Who is running the clinical trial?

Premier HealthOTHER
1 Previous Clinical Trials
24 Total Patients Enrolled
Wright State UniversityLead Sponsor
46 Previous Clinical Trials
55,158 Total Patients Enrolled
Paul J Hershberger, PhDPrincipal InvestigatorWright State University Boonshoft School of Medicine
1 Previous Clinical Trials
~100 spots leftby Jun 2028